Research output per year
Research output per year
Research output
- 3 Article
Search results
-
2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Meyer, T., Fox, R., Ma, Y. T., Ross, P., James, M. W., Sturgess, R., Stubbs, C., Stocken, D. D., Wall, L., Watkinson, A., Hacking, N., Evans, T. R. J., Collins, P., Hubner, R. A., Cunningham, D., Primrose, J. N., Johnson, P. J. & Palmer, D. H., 23 Jun 2017, (E-pub ahead of print) In: The Lancet Gastroenterology & Hepatology.Research output: Contribution to journal › Article › peer-review
Open AccessFile371 Citations (Scopus)208 Downloads (Pure) -
2016
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., Gerolami, R., Masi, G., Ross, P. J., Song, T., Bronowicki, J.-P., Ollivier-Hourmand, I., Kudo, M., Cheng, A.-L., Llovet, J. M. & Finn, R. S. & 4 others, , 6 Dec 2016, (E-pub ahead of print) In: Lancet.Research output: Contribution to journal › Article › peer-review
Open AccessFile2811 Citations (Scopus)3042 Downloads (Pure) -
2014
Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer
Yip, C., Goh, V., Davies, A., Gossage, J., Mitchell-Hay, R., Hynes, O., Maisey, N., Ross, P., Gaya, A., Landau, D., Cook, G., Griffin, N. & Mason, R., 1 May 2014, In: European Radiology. 24, 5, p. 998-1005 8 p.Research output: Contribution to journal › Article › peer-review
182 Citations (Scopus)